Israel Develops Cancer Vaccine

In what is being called, a breakthrough:

Vaxil’s groundbreaking therapeutic vaccine, developed in Israel, could keep about 90 percent of cancers from coming back.
As the world’s population lives longer than ever, if we don’t succumb to heart disease, strokes or accidents, it is more likely that cancer will get us one way or another. Cancer is tough to fight, as the body learns how to outsmart medical approaches that often kill normal cells while targeting the malignant ones.

n a breakthrough development, the Israeli company Vaxil BioTherapeutics has formulated a therapeutic cancer vaccine, now in clinical trials at Hadassah University Medical Center in Jerusalem. If all goes well, the vaccine could be available about six years down the road, to administer on a regular basis not only to help treat cancer but in order to keep the disease from recurring.
The vaccine is being tested against a type of blood cancer called multiple myeloma. If the substance works as hoped — and it looks like all arrows are pointing that way — its platform technology VaxHit could be applied to 90 percent of all known cancers, including prostate and breast cancer, solid and non-solid tumors…

Read on here.

 

Aids Vaccine ‘works in monkeys’

BBC reports:

A new vaccine can protect macaques against the monkey equivalent of HIV and could provide a fresh approach to an HIV vaccine, a study suggests.

US researchers say the vaccine offered protection to 13 of 24 rhesus macaques treated in the experiment.

In 12 of the monkeys, the vaccine was still effective 12 months later.

They claim the work, published in the journal Nature, could “significantly contribute” to the development of an effective HIV/Aids vaccine…

Read on here.